Nsclc Websites
Rigel Pharmaceuticals
Rigel Pharmaceuticals, Inc. is a clinical-stage biotechnology company focused on the discovery and development of novel, small-molecule drugs for the treatment of immune diseases and cancers.
Advanced NS NSCLC Treatment | ALIMTA® (pemetrexed for injection)
Learn how ALIMTA may help treat advanced nonsquamous non-small cell lung cancer. Find information about ALIMTA and platinum chemotherapy (carboplatin or cisplatin) in combination with KEYTRUDA® (pembrolizumab).
Vicus Therapeutics - Bringing Breakthrough Combination Immunotherapies
Vicus Therapeutics brings breakthrough and low cost adjunct therapies to patients with cancer
IRESSA® (gefitinib) | Information and resources
Learn about IRESSA (gefitinib), now approved for first-line treatment of EGFR mutation–positive patients with metastatic NSCLC
Healthcare Professional Site | OPDIVO® (nivolumab)
Learn about OPDIVO® for patients with Previously Treated Metastatic Squamous and Non-Squamous Non-Small Cell Lung Cancer (NSCLC). Please see Indication and Important Safety Information.
First-line Treatment of Metastatic Squamous Non-Small Cell Lung Cancer
Portrazza in combination with gemcitabine and cisplatin, is the first approved biologic for the treatment of patients who are chemo-naive for their metastatic non-small cell lung cancer.
The Best Oncologist TM
The site gives information about cancer, cancer treatment, cancer drugs, links to oncology journals, links to oncology sites, information about cancer related conferences, both in english and Arabic
Lipoplatin™ Global
Chemotherapy Drug: Liposomal Cisplatin Suspension for Injection by Regulon
Home | Living With ALK
Empower yourself or a loved one with ALK+ lung cancer through helpful information on living with ALK from treatment options to lifestyle tips
OPDIVO® (nivolumab) | Patient Gateway
OPDIVO® (nivolumab) is a prescription medication. Read about its indications, side effects, and more.
Rigel Pharmaceuticals
Rigel Pharmaceuticals, Inc. is a clinical-stage biotechnology company focused on the discovery and development of novel, small-molecule drugs for the treatment of immune diseases and cancers.
ATEZOLIZUMAB | ROCHE
ROCHE provides information for healthcare professionals who are prescribing Atezolizumab